A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Denver is a pivotal hub for clinical trials, thanks to its sturdy healthcare network and renowned medical research institutions. Prominent centers such as the University of Colorado Anschutz Medical Campus, Denver Health, and Children’s Hospital Colorado are at the forefront of groundbreaking studies focusing on areas including cancer research, neurological disorders, and chronic diseases.
Denver's strong emphasis on collaboration among healthcare providers, researchers, and community organizations fosters an environment conducive to medical advancements. By participating in clinical trials in Denver, individuals not only gain access to cutting-edge therapies but also contribute significantly to the progress of medical science.
Why choose Denver for clinical trials?
Denver boasts a diverse population which helps increase the reliability and relevance of research outcomes. The city is also home to top-tier medical research facilities known for innovative approaches to healthcare and a strong emphasis on medical breakthroughs.
Choosing to participate in a clinical trial in Denver means contributing to vital medical research while benefiting from a well-coordinated and supportive clinical research infrastructure. This environment not only promotes advancements in medical science but also provides participants with access to pioneering therapies and specialized care throughout the study.
Common conditions studied in Denver
In Denver, a range of medical conditions and diseases are the focus of clinical trials, taking advantage of the city's cutting-edge research institutions and expert healthcare professionals.
Chronic diseases
Chronic diseases like diabetes, hypertension, and heart disease are prevalent in Denver, and many clinical trials seek to address these conditions. Research initiatives often investigate lifestyle interventions, such as diet and exercise modifications, alongside new medications that aim to manage these diseases more effectively. By evaluating novel therapeutic approaches, these trials contribute to the ongoing efforts to reduce the burden of chronic illnesses and enhance patient outcomes.
Neurological disorders
Denver is actively involved in clinical trials targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS). Research teams work to develop and test new therapies that may slow disease progression or alleviate symptoms. This includes disease-modifying treatments aimed at altering the course of these conditions, as well as cognitive interventions designed to enhance cognitive function and overall quality of life for patients and their families.
Respiratory conditions
Due to Denver's unique altitude and climate, clinical trials focusing on respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) are particularly relevant. Researchers study new treatment modalities that take into account the local environment, which can exacerbate respiratory issues. Trials may include evaluating novel inhalers, biologic therapies, and preventive strategies aimed at reducing flare-ups and improving lung function.
Mental health conditions
Mental health conditions such as depression, anxiety, and post-traumatic stress disorder (PTSD) are also significant areas of research in Denver. Clinical trials in this field often assess new pharmacological treatments, such as antidepressants and anxiolytics, as well as therapeutic approaches like cognitive behavioral therapy and mindfulness-based interventions.
By exploring innovative treatments, these studies aim to enhance mental health care and provide effective solutions for individuals facing mental health challenges.
Cancer
Denver is a hub for cancer research, particularly at the University of Colorado Cancer Center, which is one of the National Cancer Institute's designated comprehensive cancer centers. Clinical trials in this area encompass various cancers, including breast, lung, and prostate cancer.
Researchers are exploring innovative treatments, such as immunotherapy, which harnesses the body's immune system to fight cancer, and targeted therapies that focus on specific genetic markers. These trials often aim to improve survival rates and quality of life for patients undergoing treatment.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Pediatrics
Children's Hospital Colorado is a leader in pediatric clinical trials, addressing various conditions affecting children, such as pediatric cancers, congenital disorders, and developmental issues. These trials focus on creating tailored treatments that consider the unique needs of young patients. The research often includes evaluating new drugs, surgical techniques, and comprehensive care models designed to improve health outcomes for children.
Local regulations and guidelines
In Denver, clinical trials are governed by a robust framework of regulations to ensure participant safety, ethical conduct, and scientific integrity. Key federal regulations, including those from the Food and Drug Administration (FDA) and the Common Rule established by the Department of Health and Human Services, dictate the standards for conducting research involving human subjects. Each trial must receive approval from an Institutional Review Board (IRB), which evaluates the ethical considerations, informed consent process, and risk-benefit analysis.
Colorado state regulations complement these federal guidelines, focusing on the protection of participants’ rights and the confidentiality of their data. The informed consent process is crucial, ensuring participants understand the nature of the trial, potential risks, and their rights. Throughout the study, ongoing oversight from regulatory authorities is maintained, requiring researchers to report adverse events and study results, thus promoting accountability and transparency in clinical research.
Benefits of participating in clinical trials
Participating in a clinical trial presents a unique chance for individuals to access groundbreaking therapies and treatments before they become widely available to the public. Throughout the study, participants benefit from personalized care provided by dedicated healthcare professionals who closely monitor their health and progress. This vigilant oversight ensures any side effects are effectively managed and the advantages of the experimental therapies are fully realized.
Involvement in clinical trials is crucial for advancing medical research and fostering innovation, often resulting in pivotal discoveries that improve the treatment and prevention of a wide range of health issues. By enrolling in these studies, participants secure early access to potentially life-changing interventions while playing an important role in enhancing the scientific community’s knowledge of diseases and the efficacy of different treatment approaches.
How to enroll in a clinical trial in Denver
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.